Ontology highlight
ABSTRACT:
SUBMITTER: Chen R
PROVIDER: S-EPMC7245927 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature
Chen Ruqin R Manochakian Rami R James Lauren L Azzouqa Abdel-Ghani AG Shi Huashan H Zhang Yan Y Zhao Yujie Y Zhou Kexun K Lou Yanyan Y
Journal of hematology & oncology 20200524 1
Advanced non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with a poor prognosis and no known cure. Survival time is often short because of limited treatment options. Recent advances in targeted therapy and immunotherapy have changed the landscape for the treatment of advanced NSCLC. In the last 10 years, the US Food and Drug Administration (FDA) has approved more than 17 new medications for this devastating disease and more are coming. Molecular and immunogenic testing ...[more]